About JaxBio
JaxBio is a company based in Netanya (Israel) founded in 2020 by Dror Feldheim, Joel Bar El, Shahar Zirkin, and Yuval Ebenstein. JaxBio has raised $6 million across 4 funding rounds from investors including European Union. JaxBio offers products and services including Blood Test and AI Platform. JaxBio operates in a competitive market with competitors including Abingdon Health, Genoptix, SkylineDX, Precipio Diagnostics and Biofluidica, among others.
- Headquarter Netanya, Israel
- Founders Dror Feldheim, Joel Bar El, Shahar Zirkin, Yuval Ebenstein
- SectorsHealthcare
- Website jaxbio.com
- Social LinkedIn X
- Total Equity Funding$6M (USD)
in 4 rounds
- Latest Funding Round$2.73M (USD), Grant
Jul 2024
- Investors
Products & Services of JaxBio
JaxBio offers a comprehensive portfolio of products and services, including Blood Test and AI Platform.
Enables fast and sensitive early detection of cancer via blood biomarkers.
Utilizes AI to identify cancer types and stages from blood samples.
Funding Insights of JaxBio
JaxBio has successfully raised a total of $6M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $2.73 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6M
- Total Rounds 4
- Last Round Grant — $2.73M
- First Round $6M
(Jun 2022)
- Investors Count 1
All 4 funding rounds of JaxBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $2.73M | Grant | – | – | |
| Jan 2023 | $9.08M | Grant | – | – | |
| Jan 2023 | $1.9M | Grant | – | – | |
| Jun 2022 | $6M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in JaxBio
JaxBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for JaxBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of JaxBio
4 people are tracked at JaxBio (4 in leadership).
| Name | Role | Group |
|---|---|---|
Dror Feldheim | Co-Founder | Leadership |
Joel Bar El | Co-Founder | Leadership |
Shahar Zirkin | Co-Founder | Leadership |
Yuval Ebenstein | Co-Founder | Leadership |
Complete people profiles for JaxBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of JaxBio
3 dated milestones of JaxBio across 4 years, from founding to its latest funding, stage changes and deals.
- Founded JaxBio is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Grant, of $2.7M.
Competitors of JaxBio
JaxBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Genoptix, SkylineDX, Precipio Diagnostics and Biofluidica, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abingdonhealth.com | 2008 | York, United Kingdom | $24.05M | 151 | Developer of immunoassays for diagnostic purposes | |
| genoptix.com | 1999 | Carlsbad, United States | $33.26M | 46 | Oncology diagnostics and informatics services | |
| skylinedx.com | 2005 | Rotterdam, Netherlands | – | – | Gene expression profiling tests are provided for personalized medicine. | |
| precipiodx.com | 1997 | New Haven, United States | – | – | Cancer diagnostics and second opinion tools are offered. | |
| biofluidica.com | 2007 | Chapel Hill, United States | $18.12M | 13 | Liquid biopsy tests utilizing CTCs are provided for cancer detection. | |
| elucidaoncology.com | 2014 | Santa Barbara, United States | $81.54M | – | Nanotechnology-based particle delivery platform is developed for oncology applications. | |
| repertoire.co.jp | 2014 | Ibaraki, Japan | $6.47M | – | TCR and BCR repertoire analysis services are offered. | |
| viviabiotech.com | 2007 | Tres Cantos, Spain | $7.52M | – | Precision medicine tests for hematologic cancers are developed. |
Detailed competitors of JaxBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jaxbio
Complete news archive for JaxBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to JaxBio
10 companies that operate in the same segment as JaxBio (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about JaxBio
JaxBio was founded in 2020 and raised its 1st funding round 2 years after it was founded.
JaxBio is headquartered in Netanya, Israel. It is registered at Netanya, Central District, Israel.
JaxBio is a funded company, having raised a total of $6M across 4 funding rounds to date. The company's 1st funding round was a Seed of $6M, raised on Jun 2022.
JaxBio was founded in 2020 in Netanya, Israel, within the biotechnology sector. An AI-based chip is developed by the company for analyzing genetic and epigenetic profiles. A set of biomarkers is provided to identify various cancer types. Diagnostic tests with a multi-cancer approach are supported through the chips features. Operations focus on advancing precision diagnostics in oncology.
JaxBio's top competitors include Abingdon Health, Precipio Diagnostics and SkylineDX.
JaxBio offers Blood Test and AI Platform.
JaxBio has 1 investor. Key investors include European Union.